Published in Blood Coagul Fibrinolysis on July 01, 1999
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol (2013) 1.09
Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke. J Neurol Neurosurg Psychiatry (2003) 0.94
The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke. Iran Red Crescent Med J (2014) 0.75
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med (1992) 3.87
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (2001) 3.13
Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (2001) 2.62
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost (2006) 2.56
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol (1997) 2.35
Prevalence of left ventricular hypertrophy in a general population; The Tromsø Study. Eur Heart J (1999) 2.32
Percutaneous transluminal coronary angioplasty versus thrombolysis in acute myocardial infarction. Scand Cardiovasc J (2000) 2.03
Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse (1989) 1.99
MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev (1975) 1.97
Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth (2008) 1.93
Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol (2003) 1.91
Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res (1995) 1.89
European principles of haemophilia care. Haemophilia (2008) 1.84
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost (2008) 1.81
Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem (1996) 1.68
Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma (2001) 1.63
High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem (1991) 1.62
Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth (2004) 1.62
Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. FEBS Lett (1988) 1.59
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Effect of thapsigargin on cytoplasmic Ca2+ and proliferation of human lymphocytes in relation to AIDS. Biochim Biophys Acta (1988) 1.59
Mitral flow derived Doppler indices of left ventricular diastolic function in a general population; the Tromso study. Eur Heart J (2000) 1.58
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost (2012) 1.56
Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. Am J Clin Nutr (1999) 1.55
Plasma atrial natriuretic peptide is related to systolic but not diastolic myocardial function. Determination by echocardiography 24 h after myocardial infarction. Eur Heart J (1995) 1.43
Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost (2003) 1.43
Regulation of nickel exposure in Denmark. Contact Dermatitis (1990) 1.41
The prognostic value of exercise testing early after myocardial infarction in patients treated with thrombolytics. Eur Heart J (1995) 1.40
Effect of piroxicam in addition to continuous thoracic epidural bupivacaine and morphine on postoperative pain and lung function after thoracotomy. Acta Anaesthesiol Scand (1992) 1.40
[The Medical Products Agency and thrombolytic therapy in acute myocardial infarction]. Tidsskr Nor Laegeforen (1994) 1.39
[Violence--a field for preventive health work]. Tidsskr Nor Laegeforen (1994) 1.39
[Homocysteine and cardiovascular disease]. Ugeskr Laeger (2001) 1.39
The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter. Muscle Nerve Suppl (1995) 1.39
Traffic casualties. I. Physical and social sequelae: a follow-up of 3000 traffic accidents. Dan Med Bull (1972) 1.38
[Cheese-packers' disease--respiratory complaints at a cheese-packing dairy]. Ugeskr Laeger (1994) 1.38
Percutaneous dilatational tracheostomy versus conventional surgical tracheostomy. A clinical randomised study. Acta Anaesthesiol Scand (1998) 1.37
Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost (2009) 1.36
Identification of neck-shoulder disorders in a 1 year follow-up study. Validation Of a questionnaire-based method. Pain (2000) 1.33
General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases. Clin Chim Acta (1983) 1.30
Deletion 14q and pericentric inversion 14. J Med Genet (1978) 1.30
Disease associated balanced chromosome rearrangements: a resource for large scale genotype-phenotype delineation in man. J Med Genet (2000) 1.30
Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost (2009) 1.26
Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ (1996) 1.22
Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. Schizophr Res (2000) 1.21
Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease. Epidemiol Infect (1991) 1.20
Propionic acidemia in patients with ketotic hyperglycinemia. J Pediatr (1971) 1.20
A sensitive ELISA for von Willebrand factor (vWf:Ag). Scand J Clin Lab Invest (1987) 1.19
Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol (1990) 1.15
The Tromsø study: physical fitness, self reported physical activity, and their relationship to other coronary risk factors. J Epidemiol Community Health (1992) 1.14
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost (2006) 1.14
C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. Pediatr Res (1982) 1.14
Oesophageal spasm in patients with coronary artery spasm. Lancet (1986) 1.13
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study. J Thromb Haemost (2009) 1.13
Standardization of thromboelastography: a report from the TEG-ROTEM working group. Haemophilia (2011) 1.11
Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost (2004) 1.10
Erythrocyte destruction in different types of Starr-Edwards aortic ball valves. Circulation (1970) 1.08
Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants. Thromb Haemost (2000) 1.07
Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod (2005) 1.07
Isolation and identification of methylcitrate, a major metabolic product of propionate in patients with propionic acidemia. J Biol Chem (1972) 1.07
Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy. Lancet (1971) 1.06
Serum lactic dehydrogenase activity in patients with prosthetic heart valves: a parameter of intravascular hemolysis. Am Heart J (1970) 1.06
Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr Scand (2009) 1.06
Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Haemophilia (2005) 1.05
Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol (2001) 1.05
Suberylglycine excretion in the urine from a patient with dicarboxylic aciduria. Clin Chim Acta (1976) 1.03
A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion. Blood (2000) 1.02
Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res (1986) 1.02
GLP-1 does not not acutely affect insulin sensitivity in healthy man. Diabetologia (1996) 1.02
Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Scand J Gastroenterol (1997) 1.02
Y/autosomal translocations. Clin Genet (1976) 1.01
Pain control after dental surgery: a double-blind, randomised trial of lornoxicam versus morphine. Pain (1996) 1.01
Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments. J Neurochem (1992) 1.01
Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci (1996) 1.01
Prevalence of congenital homocystinuria in Denmark. N Engl J Med (1999) 1.01
Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands. Br J Haematol (2005) 1.01
Anal intercourse as a possible factor in heterosexual transmission of HTLV-III to spouses of hemophiliacs. N Engl J Med (1985) 1.01
Clinical use of recombinant FVIIa (rFVIIa). Transfus Sci (1998) 0.99
Total homocysteine measurement in clinical practice. Ann Clin Biochem (2000) 0.98
An outbreak of Pontiac fever among children following use of a whirlpool. Clin Infect Dis (1998) 0.98
Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.98
Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system. Br J Haematol (2001) 0.98
Low molecular weight organic acids in the urine of the newborn. Acta Paediatr Scand (1977) 0.98
Olanzapine: a basic science update. Br J Psychiatry Suppl (1999) 0.98
Glucose homeostasis during exercise in humans with a liver or kidney transplant. Am J Physiol (1995) 0.98
Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A. J Thromb Haemost (2007) 0.98
Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet (2004) 0.97
Ketoconazole and cyclosporin. Lancet (1982) 0.97
In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. J Clin Psychiatry (1997) 0.97
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol (2001) 0.96
Glutaric aciduria in progressive choreo-athetosis. Clin Genet (1978) 0.96
Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels. Thromb Haemost (1997) 0.96
3-hydroxypropionate: significance of -oxidation of propionate in patients with propionic acidemia and methylmalonic acidemia. Proc Natl Acad Sci U S A (1972) 0.96
Airway management behaviour, experience and knowledge among Danish anaesthesiologists--room for improvement. Acta Anaesthesiol Scand (2001) 0.96